Doyle, Joseph P.
Patel, Pranav H.
Doran, Sophie L. F.
Jiao, Long R.
Cunningham, David
Nicol, David
Mavroeidis, Vasileios K.
Allum, William H.
Chaudry, Asif M.
Bhogal, Ricky H.
Kumar, Sacheen
Article History
Received: 12 July 2022
Accepted: 28 August 2022
First Online: 18 October 2022
Disclosure
: Professor David Cunningham has received research grants all payable to The Royal Marsden Hospital from: MedImmune/AstraZeneca, Clovis, Eli Lilly, 4SC, Bayer, Celgene and Roche. He is also on the OVIBIO Scientific Advisory Board. No other authors report any conflicts of interest.